Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-23-054420
Filing Date
2023-10-20
Accepted
2023-10-20 17:03:06
Documents
12
Period of Report
2023-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K/A dtil-20231016.htm   iXBRL 8-K/A 48649
  Complete submission text file 0000950170-23-054420.txt   175157

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dtil-20231016.xsd EX-101.SCH 2493
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dtil-20231016_pre.xml EX-101.PRE 10621
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dtil-20231016_lab.xml EX-101.LAB 14422
6 EXTRACTED XBRL INSTANCE DOCUMENT dtil-20231016_htm.xml XML 5939
Mailing Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701
Business Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 919-314-5512
PRECISION BIOSCIENCES INC (Filer) CIK: 0001357874 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38841 | Film No.: 231337679
SIC: 2836 Biological Products, (No Diagnostic Substances)